Michael Schmertzler
Director · PTC THERAPEUTICS, INC.
IndividualSelling only18 10b5-1 trades
- 2025
- Oct 9, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Schmertzler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Gregory Almstead - $16.35M in PTCT purchases and sales in the last 12 months
- Hartley R. Rogers - $13.00M in HLNE purchases and sales in the last 12 months
- Mark Elliott Boulding - $4.08M in PTCT purchases and sales in the last 12 months
- Matthew B. Klein - $3.60M in PTCT purchases and sales in the last 12 months
- Eric Pauwels - $2.61M in PTCT purchases and sales in the last 12 months
- Emma Reeve - $2.49M in PTCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Schmertzler?
Michael Schmertzler is a corporate insider, tracked as Director of PTC THERAPEUTICS, INC. (PTCT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael Schmertzler submitted recently?
6 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Michael Schmertzler been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($6.47M) across all tracked filings.
